Oaktree Acquisition Corp. III Life Sciences
OACCNASDAQFinancial Services● Active
$10.70
+$0.05(+0.47%)
Market Cap$263035596
P/E Ratio—
52W High$10.736
52W Low$10.3
Oaktree Acquisition Corp. III Life Sciences (OACC) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · OACC · as of 2026-06-08
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2025-12 | 2024-12 |
|---|---|---|
| Revenue | ||
| Revenue | $0.00B | $0.00B |
| Cost of Revenue | $0.00B | $0.00B |
| Gross Profit | $0.00B | $0.00B |
| Gross Margin %(computed) | — | — |
| Operating Expenses | ||
| R&D Expenses | $0.00B | $0.00B |
| G&A Expenses | $0.00B | $0.00B |
| Total Operating Expenses | $0.00B | $0.00B |
| Operating Income | ($0.00B) | ($0.00B) |
| Operating Margin %(computed) | — | — |
| Interest Income | $0.01B | $0.00B |
| Interest Expense | $0.00B | $0.00B |
| Income Before Tax | $0.01B | $0.00B |
| Income Tax Expense | $0.00B | $0.00B |
| Net Income | $0.01B | $0.00B |
| Net Margin %(computed) | — | — |
| Per Share & EBITDA | ||
| EPS (Basic) | $0.30 | $0.05 |
| Wtd Avg Shares | 0.02B | 0.02B |
| EBITDA | ($0.00B) | $0.00B |
| EBITDA Margin %(computed) | — | — |
Data source: Financial Modeling Prep · Last updated: 2026-06-08 · USD · B
Explore more Oaktree Acquisition Corp. III Life Sciences data
About Oaktree Acquisition Corp. III Life Sciences (OACC) Income Statement
Oaktree Acquisition Corp. III Life Sciences (OACC) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2025, OACC reported revenue of $0.00B, gross profit of $0.00B (gross margin —), and net income of $0.01B — a net profit margin of —.
Frequently asked questions
OACC · 4 questionsOaktree Acquisition Corp. III Life Sciences (OACC) reported revenue of $0.00B for 2025, down —% year-over-year.
OACC revenueOACC salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08